BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dutra BG, da Rocha AJ, Nunes RH, Maia ACM Júnior. Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. Radiographics 2018;38:169-93. [PMID: 29320331 DOI: 10.1148/rg.2018170141] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Xie Y, Zhang Y, Yao Y, Liu D, Zhu H, Liu C, Zhu W. Structural covariance in subcortical regions in multiple sclerosis and neuromyelitis optica spectrum disorders: An MRI-based study with automated brain volumetry. Mult Scler Relat Disord 2023;70:104516. [PMID: 36669244 DOI: 10.1016/j.msard.2023.104516] [Reference Citation Analysis]
2 Yamamoto M, Okuno T, Piao JL, Shimizu M, Miyamoto K, Nukui T, Kinoshita M, Koda T, Dini Haryuni R, Mochizuki H, Sugimoto T, Nakatsuji Y. Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder. J Clin Neurosci 2023;107:129-32. [PMID: 36543044 DOI: 10.1016/j.jocn.2022.12.005] [Reference Citation Analysis]
3 Ranjan S, Dev R, Keisham MD. A sporadic case of holocord tuberculous transverse myelitis with arachnoiditis. Egypt J Radiol Nucl Med 2022;53:252. [DOI: 10.1186/s43055-022-00937-3] [Reference Citation Analysis]
4 Wingerchuk DM, Weinshenker BG, Mccormick D, Barron S, Simone L, Jarzylo L. Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder. JMCP 2022;28:S3-S27. [DOI: 10.18553/jmcp.2022.28.12-a.s1] [Reference Citation Analysis]
5 Maria E, Das S, Varghese AM, Thangheswaran H, John M. Differentially Expressed Erythrocyte Proteins in Neuromyelitis Optica Spectrum Disorders and Their Functional Annotation Using DAVID Bioinformatics Tool. Neurochem J 2022;16:465-471. [DOI: 10.1134/s1819712422040158] [Reference Citation Analysis]
6 Swarup MS, Chandola S, Batra R, Prakash A, Garg A. Radiological approach to non-compressive myelopathies. Egypt J Radiol Nucl Med 2022;53:65. [DOI: 10.1186/s43055-022-00736-w] [Reference Citation Analysis]
7 Kulkarni A, Tiwana MH, Sobieh A, Qayati M, Abbassy A, Prachi D, Abayazeed A. A Pictorial Review of Cranial Nerves Imaging Anatomy and Pathology: Part 2—Pathology. Contemporary Neurosurgery 2022;44:1-8. [DOI: 10.1097/01.cne.0000891916.50336.b0] [Reference Citation Analysis]
8 Shrestha R, Kharel G. A case report on recurrent area postrema syndrome in AQP4-IgG-positive NMOSD. Oxf Med Case Reports 2022;2022:omac109. [PMID: 36299670 DOI: 10.1093/omcr/omac109] [Reference Citation Analysis]
9 Kulkarni A, Tiwana MH, Sobieh A, Qayati M, Abbassy A, Dubey P, Abayazeed A. A Pictorial Review of Cranial Nerves Imaging Anatomy and Pathology: Part 2—Pathology. Contemporary Diagnostic Radiology 2022;45:1-8. [DOI: 10.1097/01.cdr.0000874744.50448.1f] [Reference Citation Analysis]
10 Khan MI, Garg RK, Rizvi I, Malhotra HS, Kumar N, Jain A, Verma R, Sharma PK, Pandey S, Uniyal R, Jain P. Tuberculous myelitis: a prospective follow-up study. Neurol Sci 2022;43:5615-5624. [DOI: 10.1007/s10072-022-06221-6] [Reference Citation Analysis]
11 Cabot RC, Rosenberg ES, Dudzinski DM, Baggett MV, Tran KM, Sgroi DC, Shepard JO, Mcdonald EK, Corpuz T, Marra CM, Rohatgi S, Bloom AK, Kahle KT, Haj AK. Case 25-2022: A 25-Year-Old Woman with Headache and Blurred Vision. N Engl J Med 2022;387:641-50. [DOI: 10.1056/nejmcpc2201241] [Reference Citation Analysis]
12 Nasreldein A, Farweez H, Abo Elfetoh N, Badawy ER, Mahmoud D, Hassanein S, Khedr E. Radiological characteristics of neuromyelitis optica spectrum disorder in Egypt. Clinical & Exp Neuroim 2022;13:172-181. [DOI: 10.1111/cen3.12693] [Reference Citation Analysis]
13 Song H, Zhou H, Wei S. Update on glial antibody-mediated optic neuritis. Jpn J Ophthalmol 2022. [PMID: 35895155 DOI: 10.1007/s10384-022-00932-1] [Reference Citation Analysis]
14 Cicia A, Nociti V, Bianco A, De Fino C, Carlomagno V, Mirabella M, Lucchini M. Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach. Translational Neuroscience 2022;13:191-7. [DOI: 10.1515/tnsci-2022-0231] [Reference Citation Analysis]
15 Lasrado A, Chattannavar G, Sachdeva V, Kekunnaya R. Optic chiasm, optic tract and deep white demyelination: an unusual distribution of myelin oligodendrocyte glycoprotein-associated demyelination (MOGAD), case report and review of literature. BMJ Case Rep 2022;15:e249398. [DOI: 10.1136/bcr-2022-249398] [Reference Citation Analysis]
16 Weidauer S, Arendt C. Differenzialdiagnose der zervikalen Myelitis. Radiologie up2date 2022;22:137-155. [DOI: 10.1055/a-1718-8874] [Reference Citation Analysis]
17 Paydar A, Jenner ZB, Simkins TJ, Chang Y, Hacein-bey L, Ozturk A, Birkeland A, Assadsangabi R, Raslan O, Shadmani G, Apperson M, Ivanovic V. Autoimmune disease of head and neck, imaging, and clinical review. Neuroradiol J. [DOI: 10.1177/19714009221100983] [Reference Citation Analysis]
18 Ortiz Salas P, Gaviria Carrillo M, Cortés Bernal G, Moreno Medina K, Roa L, Rodríguez Quintana J. Neuromyelitis optica spectrum disorder: do patients positive and negative for anti–aquaporin-4 antibodies present distinct entities? A Colombian perspective. Neurología (English Edition) 2022. [DOI: 10.1016/j.nrleng.2020.08.022] [Reference Citation Analysis]
19 Xie Y, Zhang Y, Yao Y, Liu D, Chen B, Zhu W. Fractional anisotropy helps to differentiate the optic nerve impairment between neuromyelitis optica spectrum disorders and multiple sclerosis. Eur Radiol 2022. [PMID: 35420298 DOI: 10.1007/s00330-022-08779-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Freddi TDAL, Ottaiano C. The optic nerve: Anatomy and pathology. Seminars in Ultrasound, CT and MRI 2022. [DOI: 10.1053/j.sult.2022.04.006] [Reference Citation Analysis]
21 Pierro A, Posa A, Addona T, Petrosino A, Galasso V, Tanzilli A, Niro S, Simone FA, Cilla S, Iezzi R. Magnetic Resonance Imaging of Autoimmune Demyelinating Diseases as a Diagnostic Challenge for Radiologists: Report of Two Cases and Literature Review. Life 2022;12:488. [DOI: 10.3390/life12040488] [Reference Citation Analysis]
22 Dalaqua M, Nascimento FBPD, Miura LK, Garcia MRT, Barbosa Junior AA, Reis F. Magnetic resonance imaging of the cranial nerves in infectious, neoplastic, and demyelinating diseases, as well as other inflammatory diseases: a pictorial essay. Radiol Bras 2022;55:38-46. [DOI: 10.1590/0100-3984.2021.0042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kim M, Choi KS, Hyun RC, Hwang I, Yun TJ, Kim SM, Kim JH. Free-water diffusion tensor imaging detects occult periependymal abnormality in the AQP4-IgG-seropositive neuromyelitis optica spectrum disorder. Sci Rep 2022;12:512. [PMID: 35017589 DOI: 10.1038/s41598-021-04490-3] [Reference Citation Analysis]
24 Das S, Chakraborty U, Dubey S, Ray BK. Radiological illusion of longitudinally extensive myelitis in multiple sclerosis. Neuroimmunology Reports 2022;2:100088. [DOI: 10.1016/j.nerep.2022.100088] [Reference Citation Analysis]
25 Li X, Zhang M, Zheng G, Li X, Chen J. Intracranial Infection. Pediatric Neuroimaging 2022. [DOI: 10.1007/978-981-16-7928-5_3] [Reference Citation Analysis]
26 H L, I B, N M, A M, O A, H B, N E. Imaging aspect of neuromyelitis optica: a case report and review of the literature. Arch Case Rep 2021;5:034-036. [DOI: 10.29328/journal.acr.1001055] [Reference Citation Analysis]
27 Khedr EM, Farweez HM, Abo Elfetoh N, Badawy ER, Hassanein S, Mahmoud DM, Nasreldein A. Area postrema syndrome in neuromyelitis optica spectrum disorder: diagnostic challenges and descriptive patterns. Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00390-5] [Reference Citation Analysis]
28 Ciolac D, Crivorucica I, Zota E, Manea D, Efremova D, Gușanu L, Crivorucica V, Ciocanu M, Groppa SA. Gray Matter-Restricted Whole Spinal Cord Involvement in a Young Woman with SARS-CoV-2 Infection. J Magn Reson Imaging 2021. [PMID: 34739141 DOI: 10.1002/jmri.27986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Tsunogae M, Yoshimura H, Matsuzaki M, Yokota S, Kawamoto M. Localised chiasmal optic neuritis in neuromyelitis optica spectrum disorder. Pract Neurol 2021:practneurol-2021-003120. [PMID: 34675122 DOI: 10.1136/practneurol-2021-003120] [Reference Citation Analysis]
30 Badrawi N, Kumar N, Albastaki U. Post COVID-19 vaccination neuromyelitis optica spectrum disorder: Case report & MRI findings. Radiol Case Rep 2021;16:3864-7. [PMID: 34659602 DOI: 10.1016/j.radcr.2021.09.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
31 Yaregal S, Bekele N, Gebrewold Y, Tadesse A. Neuromyelitis Optica Spectrum Disorder: A Case Report. Int Med Case Rep J 2021;14:643-8. [PMID: 34584464 DOI: 10.2147/IMCRJ.S334362] [Reference Citation Analysis]
32 Palasis S, Moum SJ, Aw-zoretic J. Diagnostic Imaging Approach to Pediatric Myelopathy. Advances in Clinical Radiology 2021;3:265-274. [DOI: 10.1016/j.yacr.2021.05.003] [Reference Citation Analysis]
33 Paoletti M, Muzic SI, Marchetti F, Asteggiano C, Pichiecchio A, Bastianello S. Imaging findings and diagnosis of atypical aggressive demyelinating lesions of the central nervous system. G Ital Radiol Med 2021;8. [DOI: 10.23736/s2723-9284.21.00116-7] [Reference Citation Analysis]
34 Carandini T, Sacchi L, Bovis F, Azzimonti M, Bozzali M, Galimberti D, Scarpini E, Pietroboni AM. Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysis. Mult Scler Relat Disord 2021;54:103118. [PMID: 34246019 DOI: 10.1016/j.msard.2021.103118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Sachdeva V, Kekunnaya R. Working up a child with demyelinating optic neuritis: Striking a balance! Oman J Ophthalmol 2021;14:74-7. [PMID: 34345139 DOI: 10.4103/ojo.ojo_105_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Larassati H, Estiasari R, Yunus RE, Parizel PM. State-of-the-Art Review: Demyelinating Diseases in Indonesia. Mult Scler Int 2021;2021:1278503. [PMID: 34327021 DOI: 10.1155/2021/1278503] [Reference Citation Analysis]
37 Kandemirli SG, Bathla G. Neuroimaging findings in rheumatologic disorders. J Neurol Sci 2021;427:117531. [PMID: 34130065 DOI: 10.1016/j.jns.2021.117531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Hur MH. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Presentation, Diagnosis, and Management. Pediatr Ann 2021;50:e254-8. [PMID: 34115560 DOI: 10.3928/19382359-20210519-03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Meyers SP. Intracranial Abnormalities with Diffusion Restriction. Magn Reson Imaging Clin N Am 2021;29:137-61. [PMID: 33902900 DOI: 10.1016/j.mric.2021.02.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Marcucci SB, Elkasaby M, Walch R, Zare-Shahabadi A, Mahammedi A, Abboud H, Zabeti A. Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis? Mult Scler Relat Disord 2021;52:102964. [PMID: 33915519 DOI: 10.1016/j.msard.2021.102964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Pravatà E, Roccatagliata L, Sormani MP, Carmisciano L, Lienerth C, Sacco R, Kaelin-Lang A, Cianfoni A, Zecca C, Gobbi C. Dedicated 3D-T2-STIR-ZOOMit Imaging Improves Demyelinating Lesion Detection in the Anterior Visual Pathways of Patients with Multiple Sclerosis. AJNR Am J Neuroradiol 2021;42:1061-8. [PMID: 33766824 DOI: 10.3174/ajnr.A7082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Pereira FV, Jarry VM, Castro JTS, Appenzeller S, Reis F. Pediatric inflammatory demyelinating disorders and mimickers: How to differentiate with MRI? Autoimmun Rev 2021;20:102801. [PMID: 33727154 DOI: 10.1016/j.autrev.2021.102801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ma C, Ren YD, Wang JC, Wang CJ, Zhao JP, Zhou T, Su HW. The clinical and imaging features of cerebrotendinous xanthomatosis: A case report and review of the literature. Medicine (Baltimore) 2021;100:e24687. [PMID: 33655933 DOI: 10.1097/MD.0000000000024687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Igarashi A. Congress report of 16th International Child Neurology Congress/49th annual Child Neurology Society meeting: Virtual 2020. Clin Exp Neuroimmunol 2021;12:77-80. [DOI: 10.1111/cen3.12625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Tenembaum SN. Pediatric demyelinating disease and anti‐MOG antibody. Clin Exp Neuroimmunol 2021;12:7-21. [DOI: 10.1111/cen3.12627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Eun M, Seok H. Radiological Evidence of Myelitis in Neuromyelitis Optica Spectrum Disorder: Bright Spotty Lesions. Neurol India 2021;69:1623. [DOI: 10.4103/0028-3886.333494] [Reference Citation Analysis]
47 Etemadifar M, Ashourizadeh H, Nouri H, Kargaran PK, Salari M, Rayani M, Aghababaee A, Abhari AP. MRI signs of CNS demyelinating diseases. Mult Scler Relat Disord 2021;47:102665. [PMID: 33310421 DOI: 10.1016/j.msard.2020.102665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Paul S, Mondal GP, Bhattacharyya R, Ghosh KC, Bhat IA. Neuromyelitis optica spectrum disorders. J Neurol Sci 2021;420:117225. [PMID: 33272591 DOI: 10.1016/j.jns.2020.117225] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
49 Herrera Herrera I, Garrido Morro I, Guzmán de Villoria Lebiedziejewski J, Ordoñez González C, Rovira À. Enfoque clínico-radiológico de la mielopatía no traumática. Radiología 2020;62:464-480. [DOI: 10.1016/j.rx.2020.07.004] [Reference Citation Analysis]
50 Ortiz Salas P, Gaviria Carrillo M, Cortés Bernal G, Moreno Medina K, Roa L, Rodríguez Quintana J. Espectro de neuromielitis óptica: ¿seropositivo para la anticuaporina es una entidad diferente de los pacientes que son seronegativos? Una perspectiva de Colombia. Neurología 2020. [DOI: 10.1016/j.nrl.2020.08.018] [Reference Citation Analysis]
51 Carnero Contentti E, Delgado-garcía G, López PA, Criniti J, Pettinicchi JP, Correa-díaz EP, Soto de Castillo I, Daccach Marques V, Tkachuk V, Cristiano E, Serva Braga Diéguez G, dos Santos AC, Castillo MC, Patrucco L, Álvarez Pucha MO, Miño Zambrano JE, Gómez-figueroa E, Rivas-alonso V, Flores-rivera J, Caride A, Rojas JI. Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study. Multiple Sclerosis and Related Disorders 2020;46:102558. [DOI: 10.1016/j.msard.2020.102558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Herrera Herrera I, Garrido Morro I, Guzmán de Villoria Lebiedziejewski J, Ordoñez González C, Rovira À. Clinical-radiological approach to nontraumatic myelopathy. Radiología (English Edition) 2020;62:464-80. [DOI: 10.1016/j.rxeng.2020.07.004] [Reference Citation Analysis]
53 Chhabda S, Malik P, Reddy N, Muthusamy K, Mirsky D, Sudhakar S, Mankad K. Relapsing Demyelinating Syndromes in Children: A Practical Review of Neuroradiological Mimics. Front Neurol 2020;11:627. [PMID: 32849169 DOI: 10.3389/fneur.2020.00627] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Cai MT, Zheng Y, Shen CH, Yang F, Fang W, Zhang YX, Ding MP. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder. Mult Scler 2021;27:871-82. [PMID: 32672091 DOI: 10.1177/1352458520939008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
55 Ismail II, Ahmed SF, Al-Hashel JY, Abdelnabi EA, Alroughani R. Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait. Clin Neurol Neurosurg 2020;196:106047. [PMID: 32604036 DOI: 10.1016/j.clineuro.2020.106047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Li A, Jiang X, Zhong M, Li N, Tao Y, Wu W, Yang C, Wang H, Min L, Ma Y, Deng W. Intractable hiccups as a rare gastrointestinal manifestation in severe endocrine and metabolic crisis: case report and review of the literature. Therapeutic Advances in Endocrinology 2020;11:204201882093430. [DOI: 10.1177/2042018820934307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
57 Hsu Y, Chou MC, Yeh PS, Wu TC, Ko CC, Chen TY. Magnetic-Resonance Diffusion-Tensor Tractography in the Diagnosis of Tumefactive Spinal-Cord Lesions in Neuromyelitis Optica. Diagnostics (Basel) 2020;10:E401. [PMID: 32545605 DOI: 10.3390/diagnostics10060401] [Reference Citation Analysis]
58 Li H, Yang L, Wu Z, Zhou L, Bao Y, Geng D, Quan C, Li Y. Brain MRI features of Chinese Han patients with MOG-antibody disease. Mult Scler Relat Disord 2020;43:102167. [PMID: 32447248 DOI: 10.1016/j.msard.2020.102167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Cheo SW, Low QJ, Tan YA, Chia YK. Images of the month: Intractable vomiting and neuromyelitis optica spectrum disorder. Clin Med 2020;20:e20-e21. [DOI: 10.7861/clinmed.2020-0019] [Reference Citation Analysis]
60 Rauschecker AM, Rudie JD, Xie L, Wang J, Duong MT, Botzolakis EJ, Kovalovich AM, Egan J, Cook TC, Bryan RN, Nasrallah IM, Mohan S, Gee JC. Artificial Intelligence System Approaching Neuroradiologist-level Differential Diagnosis Accuracy at Brain MRI. Radiology. 2020;295:626-637. [PMID: 32255417 DOI: 10.1148/radiol.2020190283] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
61 Zhang H, Xian J. Recent advances in magnetic resonance imaging of optic neuritis. Chin J Acad Radiol 2020;3:14-18. [DOI: 10.1007/s42058-020-00026-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Padilha IG, Fonseca APA, Pettengill ALM, Fragoso DC, Pacheco FT, Nunes RH, Maia ACM, da Rocha AJ. Pediatric multiple sclerosis: from clinical basis to imaging spectrum and differential diagnosis. Pediatr Radiol 2020;50:776-92. [DOI: 10.1007/s00247-019-04582-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
63 Bot JCJ, Mazzai L, Hagenbeek RE, Ingala S, van Oosten B, Sanchez-Aliaga E, Barkhof F. Brain miliary enhancement. Neuroradiology 2020;62:283-300. [PMID: 31925469 DOI: 10.1007/s00234-019-02335-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
64 Krainik A, Casselman JW. Imaging Evaluation of Patients with Cranial Nerve Disorders. IDKD Springer Series 2020. [DOI: 10.1007/978-3-030-38490-6_12] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Atsina K. MRI in Cord Lesions. MRI of the Spine 2020. [DOI: 10.1007/978-3-030-43627-8_10] [Reference Citation Analysis]
66 Ceccarelli A, Mifsud VA, Dogar A, Hussain SI. Seropositive neuromyelitis optica spectrum disorder in Emirati patients: A case series. J Clin Neurosci 2020;72:185-90. [PMID: 31859181 DOI: 10.1016/j.jocn.2019.11.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT. Optic neuritis in the era of biomarkers. Surv Ophthalmol 2020;65:12-7. [PMID: 31425702 DOI: 10.1016/j.survophthal.2019.08.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
68 Faizy TD, Broocks G, Frischmuth I, Westermann C, Flottmann F, Schönfeld MH, Nawabi J, Leischner H, Kutzner D, Stellmann J, Heesen C, Fiehler J, Gellißen S, Hanning U. Spectrally fat-suppressed coronal 2D TSE sequences may be more sensitive than 2D STIR for the detection of hyperintense optic nerve lesions. Eur Radiol 2019;29:6266-74. [DOI: 10.1007/s00330-019-06255-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
69 Miki Y. Magnetic resonance imaging diagnosis of demyelinating diseases: An update. Clin Exp Neuroimmunol 2019;10:32-48. [DOI: 10.1111/cen3.12501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
70 Sudhakar SV, Muthusamy K, Shroff M. Imaging of Childhood Inflammatory Brain Diseases. Top Magn Reson Imaging 2018;27:409-31. [PMID: 30516693 DOI: 10.1097/RMR.0000000000000187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Mohajeri Moghaddam S, Bhatt AA. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights Imaging 2018;9:511-26. [PMID: 29949034 DOI: 10.1007/s13244-018-0608-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
72 Saber M, Gaillard F. Neuromyelitis optica spectrum disorder. Radiopaedia.org 2008. [DOI: 10.53347/rid-1218] [Reference Citation Analysis]